Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Resmed Inc (RMD)

Resmed Inc (RMD)
217.00 x 1 228.00 x 1
Post-market by (Cboe BZX)
219.70 -1.41 (-0.64%) 03/21/25 [NYSE]
217.00 x 1 228.00 x 1
Post-market 228.00 +8.30 (+3.78%) 19:20 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
217.03
Day High
221.20
Open 220.09
Previous Close 221.11 221.11
Volume 1,171,700 1,171,700
Avg Vol 1,016,045 1,016,045
Stochastic %K 13.85% 13.85%
Weighted Alpha +6.33 +6.33
5-Day Change -4.46 (-1.99%) -4.46 (-1.99%)
52-Week Range 172.19 - 263.05 172.19 - 263.05
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,266,680
  • Shares Outstanding, K 146,867
  • Annual Sales, $ 4,685 M
  • Annual Income, $ 1,021 M
  • EBIT $ 1,605 M
  • EBITDA $ 1,821 M
  • 60-Month Beta 0.74
  • Price/Sales 6.93
  • Price/Cash Flow 23.96
  • Price/Book 6.18

Options Overview Details

View History
  • Implied Volatility 30.64% ( +0.15%)
  • Historical Volatility 27.19%
  • IV Percentile 41%
  • IV Rank 20.96%
  • IV High 63.20% on 08/01/24
  • IV Low 22.00% on 05/09/24
  • Put/Call Vol Ratio 1.37
  • Today's Volume 618
  • Volume Avg (30-Day) 379
  • Put/Call OI Ratio 3.38
  • Today's Open Interest 22,006
  • Open Int (30-Day) 20,919

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.37
  • Number of Estimates 6
  • High Estimate 2.41
  • Low Estimate 2.32
  • Prior Year 2.13
  • Growth Rate Est. (year over year) +11.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
217.03 +1.23%
on 03/21/25
Period Open: 231.69
243.37 -9.73%
on 03/10/25
-11.99 (-5.18%)
since 02/21/25
3-Month
217.03 +1.23%
on 03/21/25
Period Open: 237.27
263.05 -16.48%
on 01/30/25
-17.57 (-7.41%)
since 12/20/24
52-Week
172.19 +27.59%
on 04/17/24
Period Open: 193.73
263.05 -16.48%
on 01/30/25
+25.97 (+13.41%)
since 03/21/24

Most Recent Stories

More News
Is West Pharmaceutical Services Stock Underperforming the S&P 500?

West Pharmaceutical Services has lagged behind the broader S&P 500 Index over the past year, but analysts remain highly optimistic about its future growth potential.

$SPX : 5,667.56 (+0.08%)
RMD : 219.70 (-0.64%)
WST : 228.68 (+0.51%)
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

RMD : 219.70 (-0.64%)
MASI : 165.82 (-2.17%)
PODD : 268.32 (+1.10%)
IRTC : 104.49 (+0.14%)
DXCM : 73.80 (-1.74%)
Is ResMed Stock Outperforming the Dow?

Despite ResMed’s outperformance relative to the Dow Jones over the past year, analysts are cautiously optimistic about the stock’s prospects.

RMD : 219.70 (-0.64%)
$DOWI : 41,985.35 (+0.08%)
ISRG : 492.49 (+0.14%)
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

RMD.AX : 35.120 (-0.40%)
RMD : 219.70 (-0.64%)
2 Large-Cap Stocks with Exciting Potential and 1 to Avoid

2 Large-Cap Stocks with Exciting Potential and 1 to Avoid

NOC : 490.72 (+0.30%)
RMD : 219.70 (-0.64%)
PWR : 268.22 (-1.06%)
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

For Immediate ReleaseChicago, IL – March 13, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVDA : 117.70 (-0.70%)
RMD : 219.70 (-0.64%)
GEHC : 81.49 (-0.39%)
MDT : 90.33 (-0.98%)
NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

The medical device industry is undergoing a profound change in 2025, driven by advancements in generative AI and agentic AI. At the forefront of this revolution are players like NVIDIA NVDA, whose AI computing...

NVDA : 117.70 (-0.70%)
RMD : 219.70 (-0.64%)
GEHC : 81.49 (-0.39%)
MDT : 90.33 (-0.98%)
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

RMD.AX : 35.120 (-0.40%)
RMD : 219.70 (-0.64%)
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

RMD : 219.70 (-0.64%)
MASI : 165.82 (-2.17%)
IRTC : 104.49 (+0.14%)
PODD : 268.32 (+1.10%)
DXCM : 73.80 (-1.74%)
VEEV Stock Gains Following Latest Availability of HCP Access Data

Veeva Systems Inc. VEEV, on Tuesday, announced Veeva CRM Pulse. It is a data subscription that provides quarterly healthcare professional (HCP) access and multichannel engagement metrics for the life sciences...

BSX : 100.69 (-0.81%)
RMD : 219.70 (-0.64%)
VEEV : 236.77 (+0.39%)
CAH : 131.89 (-0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 225.76
2nd Resistance Point 223.48
1st Resistance Point 221.59
Last Price 219.70
1st Support Level 217.42
2nd Support Level 215.14
3rd Support Level 213.25

See More

52-Week High 263.05
Fibonacci 61.8% 228.34
Last Price 219.70
Fibonacci 50% 217.62
Fibonacci 38.2% 206.90
52-Week Low 172.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals